Clinical Trial NCT05116787
Trial
BioCryst – BCX9930-203 REDEEM-2 (NCT05116787)
Clinical trial ID
NCT05116787
Drug name
BCX9930
Company:
BioCryst
Drug trade name
---
Clinicaltrials.gov
Learn more
Phase of study
2
Current status
Active, not recruiting
Start
10/2021
Substance
Low molecular compound
Research question
Monotherapy vs placebointreatment naive patients
Delivery method of drug
Oral
Frequency
2 x daily
Clinical trial locations
Malaysia South Africa